Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Cash from Financing Activities (2018 - 2025)

Historic Cash from Financing Activities for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $5.0 million.

  • Viemed Healthcare's Cash from Financing Activities rose 19619.94% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 14304.37%. This contributed to the annual value of -$3.7 million for FY2024, which is 23053.79% down from last year.
  • According to the latest figures from Q3 2025, Viemed Healthcare's Cash from Financing Activities is $5.0 million, which was up 19619.94% from -$671000.0 recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Cash from Financing Activities registered a high of $11.3 million during Q2 2023, and its lowest value of -$5.6 million during Q2 2022.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$1.3 million (2024), whereas its average is -$988842.1.
  • As far as peak fluctuations go, Viemed Healthcare's Cash from Financing Activities surged by 30171.92% in 2023, and later plummeted by 353589.74% in 2024.
  • Quarter analysis of 5 years shows Viemed Healthcare's Cash from Financing Activities stood at -$551000.0 in 2021, then tumbled by 783.85% to -$4.9 million in 2022, then surged by 37.78% to -$3.0 million in 2023, then soared by 113.33% to $404000.0 in 2024, then surged by 1146.78% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, -$671000.0 for Q2 2025, and -$1.7 million during Q1 2025.